25,729 articles
Engineered cardiac patch
An engineered cardiac patch is a laboratory-grown sheet of heart muscle implanted on an injured heart to add contractile tissue and support repair after a heart attack.
English Title study
English Title study is trial NCT07273292, "Autonomic Dysfunction in NMOSD and MS: A Comparative Study," an observational bedside cardiovascular reflex-test study of 100 adults comparing autonomic dysfunction patterns between NMOSD and MS.
Enhanced community quarantine in Luzon
Enhanced community quarantine in Luzon: Duterte's COVID-19 lockdown of Luzon island declared March 16, 2020 (Proclamation 929), effective March 17, extended to April 30 and then May 15 in high-risk areas, with strict home quarantine, suspended transport, and essential-only economy.
Enhanced external counterpulsation
Enhanced external counterpulsation, or EECP, is a noninvasive therapy for chronic angina in which pneumatic cuffs on the legs inflate during diastole to improve coronary blood flow.
Enhanced physiological tremor
Enhanced physiological tremor (EPT), enhanced physiologic tremor, ICD-11 8A04.0: a visible, low-amplitude, high-frequency (8-12 Hz) bilateral action tremor caused by reversible amplification of normal physiological tremor by anxiety, caffeine, drugs, or hyperthyroidism, distinct from essential tremor.
Enhanced recovery after surgery
Enhanced recovery after surgery (ERAS), also called fast-track rehabilitation, is a standardized multidisciplinary perioperative care protocol developed by Henrik Kehlet that shortens hospital stays and reduces complications across more than 20 countries.
Eniluracil
Eniluracil (5-ethynyluracil, 776C85, GW776) is an oral fluoropyrimidine analogue that irreversibly inhibits DPD, enabling oral 5-FU; phase III colorectal trials failed equivalence and development stopped.
Enisamium
Enisamium iodide (FAV00A, Amizon) is an oral isonicotinic acid derivative antiviral developed in Ukraine by Farmak, licensed in 11 CIS-region countries, inhibiting influenza and SARS-CoV-2 RNA polymerases via metabolite VR17-04.
ENISH trial
ENISH (NCT03857802) was a parallel open-label randomized trial of nurse-delivered sleep hygiene education, nine recommendations, in prediabetes and type 2 diabetes, improving PSQI sleep quality and lowering HbA1c.
Enlarged blind spot
Enlarged blind spot (cecocal scotoma), ICD-11 9D42.20: pathologic widening of the eye's normal optic-disc blind spot. Main causes are idiopathic intracranial hypertension, optic disc drusen, high myopia, and acute idiopathic blind spot enlargement syndrome.
Enlarged lymph nodes
Enlarged lymph nodes (lymphadenopathy) are abnormally sized or altered lymph nodes, >1 cm for most nodes. Usually benign and infectious; malignancy causes 1.1% of primary care cases, 4% over age 40.
Enlarged parietal foramina
Enlarged parietal foramina (EPF, Catlin marks, foramina parietalia permagna) are hereditary symmetric openings in the parietal bones from failed ossification, caused by ALX4 or MSX2 variants, autosomal dominant, prevalence 1/15,000–1/50,000, usually asymptomatic.
Enmetazobactam
Enmetazobactam (AAI101) is an Indian-invented penicillanic acid sulfone beta-lactamase inhibitor paired with cefepime as Exblifep/Orblicef, approved 2024 for complicated UTI; ALLIUM trial showed 79.1% vs 58.9% success.
Eno (drug)
Eno (Eno Fruit Salt) is an effervescent antacid powder of sodium bicarbonate, sodium carbonate, and citric acid, invented by James Crossley Eno in 1850s Newcastle, owned by Haleon, and a leading acidity-relief brand in India, Brazil, and other markets.
Enobosarm
Enobosarm (ostarine, GTx-024, MK-2866, VERU-024) is an oral nonsteroidal SARM developed for cancer cachexia; it raised lean body mass in phase 2/3 trials but won no US or EU approval and is WADA-prohibited.
Enoch Gordis
Enoch Gordis (1931–2023) was an American physician who directed the National Institute on Alcohol Abuse and Alcoholism from 1986, after founding a large alcohol treatment program in Queens, New York.
Enoxaparin sodium
Enoxaparin sodium (Lovenox, Clexane; Sanofi) is a low-molecular-weight heparin anticoagulant made by controlled depolymerization of heparin, US-approved 1993, used for DVT prophylaxis and treatment and acute coronary syndromes, with renal dose adjustment and a spinal hematoma boxed warning.
Enoximone
Enoximone (fenoximone, MDL 17,043, Perfan) is a phosphodiesterase III inhibitor with positive inotropic and vasodilating action, used short-term intravenously for acute congestive heart failure in Europe and the UK, not North America.
ENPIC study
ENPIC (Evaluation of Nutritional Practices in the Critical Care patient) is a 2018 Spanish multicenter observational study of 639 ICU patients on artificial nutrition, finding 25.6% mortality linked to severity scores, NUTRIC risk, and protein intake.
ENRICA study
ENRICA (Study on Nutrition and Cardiovascular Risk in Spain) is a nationwide cohort of about 13,000 adults aged 18+ recruited 2008–2010, with Seniors-ENRICA-1 and -2 older-adult subcohorts, studying diet, risk factors, and mortality.
Enriqueta C. Bond
Enriqueta C. Bond is an American health scientist and philanthropy leader who served as the first full-time president of the Burroughs Wellcome Fund, a private medical science foundation, from 1994 to 2008.
Ensartinib
Ensartinib (Ensacove, X-396, Beimeina) is a second-generation ALK/ROS1/MET kinase inhibitor for ALK-positive NSCLC; FDA-approved December 18, 2024 at 225 mg daily, with eXalt3 and ELEVATE trial evidence.
Ensifentrine
Ensifentrine (RPL554), marketed as OHTUVAYRE, is an inhaled dual PDE3/PDE4 inhibitor approved by the FDA in 2024 for maintenance treatment of COPD in adults, dosed 3 mg twice daily by jet nebulizer.
Ensovibep
Ensovibep (MP0420) is a five-domain DARPin antiviral by Molecular Partners and Novartis that blocks SARS-CoV-2 spike-ACE2 binding; positive in EMPATHY phase 2 but futile in hospitalized ACTIV-3/TICO patients, then deprioritized.
Ensure
Ensure, Abbott's adult oral nutritional supplement brand introduced in 1973, offers shakes and powders (Original, Plus, Max Protein, Complete, Enlive) providing complete balanced nutrition for malnourished patients, recovery, and healthy aging.
Entacapone
Entacapone (Comtan) is a reversible peripheral COMT inhibitor taken with levodopa/carbidopa to treat wearing-off motor fluctuations in Parkinson's disease; approved 1998 (EMA) and 1999 (FDA), 200 mg tablets, up to 10 daily.
Entecavir anhydrous
Entecavir anhydrous (C12H15N5O3, MW 277.28) is the water-free form of entecavir (Baraclude), a guanosine nucleoside analogue HBV reverse transcriptase inhibitor first FDA-approved March 29, 2005, dosed 0.5 or 1 mg daily for chronic hepatitis B.
Enteric anendocrinosis
Enteric anendocrinosis, or congenital malabsorptive diarrhea (OMIM 610370), is an extremely rare autosomal recessive NEUROG3 disorder causing absent intestinal enteroendocrine cells, neonatal osmotic diarrhea requiring parenteral nutrition, and variable diabetes.
Enteric coating
Enteric coating: pH-sensitive polymer film on oral dosage forms that blocks gastric release and releases drug in the intestine; polymers, compendial tests, bioequivalence, and limits.
Enteric fever
Enteric fever, typhoid and paratyphoid fever, is a systemic Salmonella enterica serovar Typhi and Paratyphi infection spread fecal-orally, causing prolonged fever; 14.3 million cases and 135,900 deaths in 2017.